Prolactin levels were decreased non-significantly in women with PCOS used LGD intervention vs. comparator groups, with a SMD of -0.43 (95% CI: -01.02 to 0.17, P = 0.16, I2 = 68%) (Table2). This evidence concerns the gene PRL and polycystic ovary syndrome.